Immunochemoradiotherapy or Immunochemotherapy Only in Patients With Extranonal Diffuse Large B-Cell Lymphoma of Stomach

Hematological Oncology - United Kingdom
doi 10.1002/hon.127_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Long-Term Follow-Up of Patients With Non-Hodgkin Primary Diffuse Large B-Cell Lymphoma of the Stomach: Better Outcome After Immunochemotherapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Antiviral Therapy and Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) With Hepatitis C (Hcv)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Diffuse Large B-Cell Lymphoma

2020English

Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Annals of Hematology
MedicineHematology
2013English

Clinical Significance of T-Cell Exhaustion in Patients With Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Safety and Activity of Ibrutinib in Combination With Durvalumab in Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B‐cell Lymphoma

American Journal of Hematology
Hematology
2019English

B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

Prognostic Nomogram for Overall Survival in Patients With Diffuse Large B‐Cell Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2019English

Unfavorable Prognostic Impact of MYC Increased Copy Number (ICN) in Patients With Diffuse Large B-Cell (DLBCL) and High-Grade Lymphoma Treated With Immunochemotherapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy